Form 8-K - Current report:
SEC Accession No. 0001367644-20-000143
Filing Date
2020-08-26
Accepted
2020-08-26 06:46:39
Documents
17
Period of Report
2020-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x08x26marvinwh.htm   iXBRL 8-K 45191
2 EXHIBIT 99 a082620boardappointsmarv.htm EX-99 5891
8 a082620boardappointsmarv001.jpg GRAPHIC 266673
9 a082620boardappointsmarv002.jpg GRAPHIC 105161
  Complete submission text file 0001367644-20-000143.txt   714624

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200825.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200825_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200825_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200825_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200825_pre.xml EX-101.PRE 14152
10 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x08x26marvinwh_htm.xml XML 4369
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 201134089
SIC: 2834 Pharmaceutical Preparations